Thought Leadership
Search results
Article | March 13, 2012
Read more
Biosimilars vs. Generics - Major Differences in the Regulatory Model
Pharmaceutical Compliance Monitor
Blog | February 14, 2012
Federal Circuit Affirms Ongoing Royalty in Bard v. W.L. Gore
Fish & Richardson
Read more
Blog | February 06, 2012
NDCA Addresses Pre-Trial Procedure for Streamlining Patent Marking Defense
Fish & Richardson
Read more
Blog | January 06, 2012
Read more
EDVA denies motion to stay payment of "sunset" royalties
Fish & Richardson
Blog | January 03, 2012
Read more
NDCA clarifies that Marking turns on what claims are asserted, not what survives to trial
Fish & Richardson
Blog | January 02, 2012
Read more
NDCA denies Daubert motion for Defendant's damages expert
Fish & Richardson
Article | December 02, 2011
Read more
Orange Book Listing Opportunities for Drug-Device Combinations
BNA Pharmaceutical Law & Industry Report
Blog | December 01, 2011
WD TN Grants New Trial on Damages after Remand Because the Reasonable Royalty Rate in the Original Verdict Was Based on the Now-Defunct 25%
Fish & Richardson
Read more
Article | November 08, 2011
Read more
Inspiration or infringement?: Examining the Janine Gordon v. Ryan McGinley Photography Case
Intellectual Property Magazine